Outlook Therapeutics, Inc. reported a net loss of $62.4M in fiscal year 2025. This represents an increase of 17.2% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Outlook Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
OTLK Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
OTLK Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Outlook Therapeutics, Inc. financials
Frequently Asked Questions
What was Outlook Therapeutics, Inc.'s net income in fiscal year 2025?
Outlook Therapeutics, Inc. reported a net loss of $62.4M in fiscal year 2025.
How fast is Outlook Therapeutics, Inc.'s net income growing?
Outlook Therapeutics, Inc. (OTLK) net income rose by 17.2% year over year, from -$75.4M to -$62.4M in fiscal year 2025.
How has Outlook Therapeutics, Inc.'s net income changed over the years?
Across the 11 fiscal years this page covers, Outlook Therapeutics, Inc. (OTLK) net income went from -$47.4M in fiscal year 2015 to -$62.4M in fiscal year 2025.
What was Outlook Therapeutics, Inc.'s net income in the most recent quarter?
Outlook Therapeutics, Inc. (OTLK) reported -$20.3M in net income in Q3 2026. This represents a decrease of 0.8% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Outlook Therapeutics, Inc. (OTLK) reported on that line in every period on record.